Auto-immune bullous skin diseases;Maladies bulleuses auto-immunes

Revue de Medecine Interne

Volumn 20, Issue 1, 1999, Pages 26-38

  Joly, P ^a  

^a Clinique Dermatologique   (France)

Author keywords

Autoantibody; Bullous pemphigoid; Pemphigus

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DESMOGLEIN; IMMUNOSUPPRESSIVE AGENT; MEMBRANE PROTEIN; PREDNISOLONE; PREDNISONE;

AUTOIMMUNE DISEASE; BULLOUS SKIN DISEASE; CROHN DISEASE; DERMATITIS HERPETIFORMIS; EPIDERMOLYSIS BULLOSA ACQUISITA; HUMAN; IMMUNOGLOBULIN DEPOSITION; IMMUNOSUPPRESSIVE TREATMENT; MUCOUS MEMBRANE PEMPHIGOID; ORAL DRUG ADMINISTRATION; PARANEOPLASTIC SYNDROME; PEMPHIGOID; PEMPHIGOID GESTATIONIS; PEMPHIGUS; PEMPHIGUS VULGARIS; PROGNOSIS; REVIEW; STEROID THERAPY; TOPICAL DRUG ADMINISTRATION;

EID: 0032747824     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(99)83006-9     Document Type: Review

References (67)

1. Stanley JR. Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody mediated diseases. J Clin Invest. 83:1989;1443-1448.
2. Anhalt GJ, Kim SC, Stanley JR, Korman NJ, Jabs DA, Kory M, et al. Paraneoplastic pemphigus, an autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med. 323:1990;1729-1735.
3. Degos T, Touraine R, Belaich S, Revuz J. Pemphigus chez un malade traité par pénicillamine pour maladie de Wilson. Bull Soc Fr Dermatol Syph. 76:1969;751-753.
4. Kaplan RP, Callen JP. Pemphigus associated diseases and induced pemphigus. Clin Dermatol. 1:1983;42-71.
5. Katz RA, Hood AF, Anahlt GJ. Pemphigus-like eruption from captopril. Arch Dermatol. 123:1987;20-21.
6. Brennen S, Bialy-Golan A, Anhalt GJ. Recognition of pemphigus antigens in drug-induced pemphigus vulgaris and pemphigus foliaceus. J Am Acad Dermatol. 36:1997;919-923.
7. Martin RL, McSweeney GW, Schneider J. Fatal pemphigus vulgaris in a patient taking piroxicam. N Engl J Med. 309:1983;795-796.
8. Simon DG, Krutchkoff D, Kaslow RA, Zarbo R. Pemphigus in Hartford Country, Connecticut from 1972 to 1977. Arch Dermatol. 116:1980;1035-1037.
9. Moraes JR, Moraes ME, Fernandez-Vina M, Diaz LA, Friedman H, Campbell IT, et al. HLA antigens and risk for evelopment of pemphigus foliaceus (fogo selvagem) in endemic areas of Brazil. Immunogenetics. 33:1991;388-391.
10. Bastuji-Garin S, Souissi R, Blum L, et al. Comparative epidemiology of pemphigus in Tunisia and France: unusual incidence of pemphigus foliaceus in young tunisian women. J Invest Dermatol. 104:1995;302-305.
11. Sinha AA, Brautbar C, Szafer F, et al. A newly characterized HLA DQb allele associated with pemphigus vulgaris. Science. 239:1988;1026-1029.
12. Firooz A, Mazhar A, Ahmed AR. Prevalence of autoimmune diseases in the family members of patients with pemphigus vulgaris. J Am Acad Dermatol. 31:1994;434-437.
13. Judd KP, Lever WF. Correlation of antibodies in skin and serum with disease severity in pemphigus. Arch Dermatol. 115:1979;428-432.
14. Golan D, Gilhar A, Shmuel Z, Moshkowitz M. Autoantibodies to epithelial cells (intercellular substance) and their correlation with clinical activity of pemphigus vulgaris. Dermatologica. 169:1984;339-341.
15. Moncada B, Kettelsen S, Hernandez-Moctezuma JL, Ramirez F. Neonatal pemphigus vulgaris: role of passively transferred pemphigus antibodies. Br J Dematol. 106:1982;465-468.
16. Anhalt GJ, Labib KS, Voorhees JJ, Beals TF, Diaz LA. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med. 306:1982;1189-1196.
17. Stanley JR, Koulu L, Thivolet C. Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies. J Clin Invest. 74:1984;313-320.
18. Eyre RW, Stanley JR. Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen. J Clin Invest. 81:1988;807-812.
19. Amagai M, Klaus-Kovtum V, Stanley JR. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell. 67:1991;869-877.
20. Wheeler GN, Parker AE, Thomas CL, Ataliotis P, Poynter D, Arnemann J, et al. Desmosomal glycoprotein DGI, a component of intercellular desmosome junctions, is related to the cadherin family of cell adhesion molecules. Proc Natl Acad Sci USA. 88:1991;4796-4800.
21. Korman N. Pemphigus. J Am Acad Dermatol. 18:1988;1219-1238.
22. Parodi A, Stanley JR, Ciaccio M, Rebora A. Epidermal antigens in pemphigus vegetans. Report of a case. Br J Dermatol. 119:1988;799-802.
23. Amerian ML, Ahmed AR. Pemphigus erythematosus. Presentation of four cases and review of the literature. J Am Acad Dermatol. 10:1984;215-222.
24. Camisa C, Helm TN, Liu YC, Valenzuela R, Allen C, Bona S, et al. Paraneoplastic pemphigus: A report of three cases including one long-term survivor. J Am Acad Dermatol. 27:1992;547-553.
25. Raison-Peyron N, Meunier L, Joly P, Pages M, Barneon G, Meynadier J. Paraneoplastic pemphigus associated with myasthenia gravis and Castleman's tumour. Eur J Dermatol. 7:1997;371-373.
26. Horn TD, Anhalt GJ. Histologic features of paraneoplastic pemphigus. Arch Dermatol. 128:1992;1091-1095.
27. Liu AY, Valenzuela R, Helm TN, Camisa C, Melton AL, Bergfeld WF. Indirect immunofluorescence on rat bladder transitional epithelium: a test with high specificity for paraneoplastic pemphigus. J Am Acad Dermatol. 28:1993;696-699.
28. Oursler JR, Labib RS, Ariss-Abdo L, Burke T, O'Keefe EJ, Anhalt GJ. Human autoantibodies against desmoplakins in paraneoplastic pemphigus. J Clin Invest. 89:1992;1775-1782.
29. Joly P, Gilbert D, Thomine E, Delpech A, Verdier S, Lauret Ph, et al. Immunofluorescence and immunoelectronmicroscopy analyses of a human monoclonal anti-epithelial cell surface antibody that recognizes a 185 kDa polypeptide: A component of the paraneoplastic pemphigus antigenic complex? J Invest Dermatol. 101:1993;339-345.
30. Joly P, Thomine E, Gilbert D, et al. Overlapping distribution of autoantibody specificities between pemphigus vulgaris and paraneoplastic pemphigus. J Invest Dermatol. 103:1994;65-72.
31. Vaillant L, Meunier L. Dermatoses bulleuses auto-immunes. Ann Dermatol Vénéréol. 124:1997;46-56.
32. Bystryn JC, Steinman NM. The adjuvant therapy of pemphigus. An update. Arch Dermatol. 132:1996;203-212.
33. Fine JD. Management of acquired bullous skin diseases. N Engl J Med. 333:1995;1475-1484.
34. Thivolet J, Barthelemy H, Rigot-Muller G, Bendelac A. Effects of cyclosporine on bullous pemphigoid and pemphigus. Lancet. i:1985;334-335.
35. Nicolas JF, Michalaki H, Peyron E, Machado P, Cozzani E, Schmitt D. Pathologie acquise de la jonction dermo-épidermique. Méd Sci. 9:1993;376-386.
36. Yancey KB. Adhesion molecules II. Interactions of keratinocytes with epidermal basement membrane. J Invest Dermatol. 104:1995;1008-1014.
37. Mueller S, Klaus-Kovtun V, Stanley JR. A 230 kDa basic protein is the major bullous pemphigoid antigen. J Invest Dermatol. 128:1989;791-794.
38. Giudice GJ, Emery DJ, Diaz LA. Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J Invest Dermatol. 99:1992;243-250.
39. Liu Z, Diaz LA, Tor JL, et al. A passive transfer model of the organ-specific auto-immunedisease: bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen BP180. J Clin Invest. 92:1993;2480-2488.
40. Joly P, Thomine E, Gilbert D, et al. Relationship between the in vivo localization and the immunoblotting pattern of antibasement membrane zone antibodies in patients with bullous pemphigoid. Arch Dermatol. 133:1997;719-724.
41. Bernard P, Vaillant L, Labeille B, et al. Incidence and distribution of subepidermal bullous skin diseases in three French regions. Arch Dermatol. 131:1995;48-52.
42. Bastuji-Garin S, Joly P, Picard C, et al. Drugs associated with bullous pemphigoid. A case-control study. Arch Dermatol. 132:1996;272-276.
43. Gammon WR, Kowalewski C, Chorzelski TP, Kumar V, Briggaman RA, Beutner EH. Direct immunofluorescence studies of sodium chloride-separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. J Am Acad Dermatol. 22:1990;664-670.
44. Bernard P, Didierjean L, Denis F, Saurat JH, Bonnetblanc JM. Heterogeneous bullous pemphigoid antibodies: detection and characterization by immunoboblotting when absent by indirect immunofluorescence. J Invest Dermatol. 92:1989;171-175.
45. Prost C, Dubertret L, Fosse M, Wechsler J, Touraine R. A routine immuno-electron microscopic technique for localizing an auto-antibody on epidermal basement membrane. Br J Dermatol. 110:1984;1-7.
46. Guillaume JC, Vaillant L, Bernard Ph, et al. Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid. Arch Dermatol. 129:1993;49-56.
47. Lebrun-Vignes B, Roujeau JC, Bernard P, et al. Prednisone is more effective than prednisolone metasulfobenzoate in the treatment of bullous pemphigoid. Arch Dermatol. 1999;. (à paraître).
48. Bernard P, Enginger V, Venot J, Bedane C, Bonnetblanc JM. Pronostic vital de la pemphigoïde : analyse d'une cohorte de 78 malades. Ann Dermatol Vénéréol. 122:1995;751-757.
49. Bernard P, Bedane C, Bonnetblanc JM. Anti-BP180 autoantibodies as a marker of poor prognosis in bullous pemphigoid: a cohort analysis of 94 elderly patients. Br J Dermatol. 136:1997;694-698.
50. Westerhof W. Treatment of bullous pemphigoid with topical clobetasol propionate. J Am Acad Dermatol. 20:1989;458-461.
51. Bouscarat F, Chosidow O, Picard-Dahan C, et al. Treatment of bullous pemphigoid with dapsone: retrospective study of 36 cases. J Am Acad Dermatol. 34:1996;683-684.
52. Kelly SE, Wojnarowska F. Pemphigoid gestationis. Eur J Dermatol. 4:1994;16-20.
53. Giudice GJ, Emery DJ, Zelickson BD, Anhalt GJ, Liu Z, Diaz LA. Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain. J Immunol. 151:1993;5742-5750.
54. Ferrando J, Arriaga F, Bordas X, Ercilla G, Vives J, Mascaro JM. Association of HLA-DR3 and herpes gestationis. Acta Dermatol Venereol. 61:1981;462-464.
55. Ahmed AR, Kurgis BS, Rogers RS. Cicatricial pemphigoid. J Am Acad Dermatol. 24:1991;987-1001.
56. Bernard P, Prost C, Lecerf V, et al. Studies of cicatricial pemphigoid autantibodies using direct immunoelectron microscopy and immunoblot analysis. J Invest Dermatol. 94:1990;630-635.
57. Bedane C, McMillan JR, Balding SD, et al. Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida. J Invest Dermatol. 108:1997;901-907.
58. Prost C, Labeille B, Chaussade V, Guillaume JC, Dubertret L. Immunoelectron microscopy in subepidermal autoimmune bullous diseases. J Invest Dermatol. 89:1987;567-573.
59. Tanaka T, Furukawa F, Imamura S. Epitope mapping for epidermolysis bullosa acquisita autoantibody by molecularly cloned cDNA for type VII collagen. J Invest Dermatol. 102:1994;706-709.
60. Borradori L, Caldwell JB, Briggaman RA, et al. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice. Arch Dermatol. 131:1995;590-595.
61. Joly P, Ruto F, Thomine E, Balguerie X, Delpech A, Tron F, et al. Brunsting-Perry cicatricial bullous pemphigoid: a clinical variant of localized epidermolysis bullosa. J Am Acad Dermatol. 28:1992;89-92.
62. Schattenkirchner S, Lemann M, Prost C, et al. Localized epidermolysis bullosa acquisita of the eosophagus in a patient with Crohn's disease. Am J Gastroenterol. 91:1996;1657-1659.
63. Reunala T, Mäki M. Dermatitis herpetiformis: a genetic disease. Eur J Dermatol. 3:1993;519-526.
64. Wojnarowska F, Bhogal BS, Black MM. Chronic bullous disease of childhood and linear IgA disease of adults are IgAI-mediated diseases. Br J Dermatol. 131:1994;201-204.
65. Wojnarowska F, Whitehead P, Leigh IM, Bhogal BS, Black MM. Identification of the target antigen in chronic bullous disase of childhood and linear IgA disease of adults. Br J Dermatol. 124:1991;157-162.
66. Kuechle MK, Stegemeier E, Maynard B, Gibson LE, Leiferman KM, Peters MS. Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature. J Am Acad Dermatol. 30:1994;187-192.
67. Prost C, Colonna De Lecca A, Cambemale P, et al. Diagnosis of adult linear IgA dermatosis by immunoelectromicroscopy in 16 patients with linear IgA deposits. J Invest Dermatol. 92:1989;39-45.